Provided By GlobeNewswire
Last update: Mar 27, 2024
LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced rescheduling its financial results conference call for the fourth quarter and full year 2023 to Monday, April 1st at 8:30 a.m. ET. The Company intends to file its Form 10-K with the SEC and issue a press release prior to the start of the call.
NASDAQ:NXGL (10/8/2025, 8:04:55 PM)
2.71
+0.15 (+5.86%)
NASDAQ:NXGLW (10/8/2025, 8:04:55 PM)
0.339
+0.04 (+14.49%)
Find more stocks in the Stock Screener